Search

Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy

Trial Phase 4 Completed Aug. 30, 2018

GDNF in ideopathicParkinsons Disease

Trial Phase 2 Completed Aug. 28, 2018

Mutations Associated With Parkinson s Disease

Trial N/A Terminated Aug. 28, 2018

N-Acetylcysteine for Neuroprotection in Parkinson's Disease

Trial Phase 1 Completed Aug. 27, 2018

High-intensity Group Vocal Exercise to Improve Laryngeal Function in Patients With Parkinson Disease

Trial N/A Completed Aug. 26, 2018

Sleep, Awake & Move - Part II

Trial N/A Completed Aug. 26, 2018

Pain in Parkinson's Disease With Motor Fluctuations.

Trial N/A Unknown Aug. 26, 2018

Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)

Trial Phase 2 Completed Aug. 22, 2018

Tryptophan Depletion in PD Patients Treated With STN DBS

Trial N/A Terminated Aug. 21, 2018

FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)

Trial N/A Completed Aug. 19, 2018

Autologous Mesenchymal Stem Cell Transplant for Parkinson's Disease

Trial N/A Terminated Aug. 13, 2018

A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

Trial Phase 3 Unknown Aug. 13, 2018

Drug Interaction With Genes in Parkinson's Disease

Trial N/A Unknown Aug. 12, 2018

Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528

Trial Phase 3 Completed Aug. 12, 2018

Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa

Trial N/A Completed Aug. 9, 2018

Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients

Trial Phase 1 Withdrawn Aug. 9, 2018

Transdermal Rotigotine User Surveillance Study

Trial N/A Completed Aug. 8, 2018

Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes

Trial Phase 2 Completed Aug. 7, 2018

A Comparison of Voice Amplifiers and Personal Communication Systems in Individuals With Parkinson's Disease

Trial N/A Unknown Aug. 6, 2018

A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa

Trial Phase 3 Completed Aug. 5, 2018